Article Details
Retrieved on: 2022-06-16 15:35:53
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... engineered natural killer (NK) cells and other emerging technologies for patients with hematological and solid tumors, said the organization.
Article found on: www.biopharma-reporter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here